Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
Open Access
- 1 August 1997
- journal article
- research article
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 54 (8), 605-612
- https://doi.org/10.1136/oem.54.8.605
Abstract
OBJECTIVES: To describe relative hazards in sectors of the beryllium industry, risk factors of beryllium disease and sensitisation related to work process were sought in a beryllium manufacturing plant producing pure metal, oxide, alloys, and ceramics. METHODS: All 646 active employees were interviewed; beryllium sensitisation was ascertained with the beryllium lymphocyte proliferation blood test on 627 employees; clinical evaluation and bronchoscopy were offered to people with abnormal test results; and industrial hygiene measurements related to work processes taken in 1984-93 were reviewed. RESULTS: 59 employees (9.4%) had abnormal blood tests, 47 of whom underwent bronchoscopy. 24 new cases of beryllium disease were identified, resulting in a beryllium disease prevalence of 4.6%, including five known cases (29/632). Employees who had worked in ceramics had the highest prevalence of beryllium disease (9.0%). Employees in the pebble plant (producing beryllium metal) who had been employed after 1983 also had increased risk, with a prevalence of beryllium disease of 6.4%, compared with 1.3% of other workers hired in the same period, and a prevalence of abnormal blood tests of 19.2%. Logistic regression modelling confirmed these two risk factors for beryllium disease related to work processes and the dependence on time of the risk at the pebble plant. The pebble plant was not associated with the highest gravimetric industrial hygiene measurements available since 1984. CONCLUSION: Further characterisation of exposures in beryllium metal production may be important to understanding how beryllium exposures confer high contemporary risk of beryllium disease.Keywords
This publication has 8 references indexed in Scilit:
- Machining risk of beryllium disease and sensitization with median exposures below 2 ?g/m3American Journal of Industrial Medicine, 1996
- HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium DiseaseScience, 1993
- Epidemiology of Beryllium Sensitization and Disease in Nuclear WorkersAmerican Review of Respiratory Disease, 1993
- Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.1993
- Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium diseaseJournal of Allergy and Clinical Immunology, 1991
- Pathologic and Immunologic Alterations in Early Stages of Beryllium Disease: Re-examination of Disease Definition and Natural HistoryAmerican Review of Respiratory Disease, 1989
- Transbronchoscopic Lung Biopsy in SarcoidosisChest, 1980
- EPIDEMIOLOGY STANDARDIZATION PROJECT1978